A European perspective on social anxiety disorder

European Psychiatry

Volumn 15, Issue 1, 2000, Pages 5-16

  Lecrubier, Y ^a   Wittchen, H U ^b   Faravelli, C ^c   Bobes, J ^d   Patel, A ^e   Knapp, M ^e  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c UNIVERSITY OF FLORENCE   (Italy)

^d Facultad de Medicina   (Spain)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Co morbidity; Disability; Europe; Prevalence; Social anxiety disorder; Socioeconomic

Indexed keywords

ANXIETY NEUROSIS; DEPRESSION; ECONOMIC ASPECT; EUROPE; HEALTH CARE UTILIZATION; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SOCIAL PHOBIA; SUBSTANCE ABUSE; UNEMPLOYMENT;

EID: 0034094788     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(00)00216-9     Document Type: Review

References (43)

1. . Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 4th ed. 1994;Washington, DC: APA.
2. Angst J. Comorbidity of panic disorder in a community sample. Clin Neuropharmacol. 15 Suppl 1:1992;176-177.
3. Angst J., Dobler-Mikola A. The Zurich Study: anxiety and phobia in young adults. Eur Arch Psychiatr Neurol Sci. 235:1995;171-178.
4. Arillo A., Aguinaga I., Guillén F. Prevelencia de enfermedades mentales en mujeres de una zona urbana. Aten Primaria. 21:1998;5.
5. Aspendorf J.B. Shyness as a final common pathway for two different kinds of inhibition. J Pers Social Psychol. 57:1989;481-492.
6. Ballenger J.C., Davidson J.R.T., Lecrubier Y., Nutt D.J., Bobes J., Beidel D.C., et al. Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 59:1998;54-60.
7. Bisserbe J.C., Weiller E., Boyer P., Lepine J.P., Lecrubier Y. Social phobia in primary care: level of recognition and drug use. Int Clin Psychopharmacol. 11:1996;25-28.
8. Bijl R.V., Ravelli A., VanZessen G. Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatr Epidemiol. 33:1998;587-595.
9. Bobes J., Badía X., Lque A., García M., González M.P., Dal-Ré R. Validación de las versiones en español do los cuestionarios Liebowitz Social Anxiety Scale. Social Anxiety and Distress Scale y Sheehan Disability Inventory para la evaluación de la fobia social. Med Clin (Barc). 112:1999;530-538.
10. Boyd J.H., Rae D.S., Thompson J.W., Burns B.J., Bourdon K., Locke B.Z., et al. Phobia: prevalence and risk factors. Soc Psychiatry Psychiatr Epidemiol. 25:1990;314-323.
11. Carta M.G., Rudas N. Uno studio sul benessere psicologico degli emigratti sari a Parigi a confronto con I sardi residenti in Sardegna e con I parigini. In: Progressi in Psichiatria Transculturale, Parte IV. 1998;97-118 Cagliari: CUEC Editore.
12. Davidson J.R.T., Hughes D.L., George L.K., Blazer D.G. The epidemiology of social phobia: findings from the Duke epidemiological Catchment Area Study. Psychol M. 23:1993;709-718.
13. Davidson J.R.T. Pharmacotherapy of social anxiety disorder. J Clin Psychiatry. 59:1998;47-53.
14. Degonda M., Angst J. The Zurich Study. XX. Social phobia and agoraphobia. Eur Arch Psychiatry Clin Neurosci. 243:1993;95-102.
15. Eaton W.W., Dryman A., Weissman M.M. Panic and phobia. Robins L.N, Regier D.A. Psychiatric disorders in America: The epidemiologic catchment area study. 1991;155-179 New York: The Free Press.
16. Faravelli C., Guerrini Degl'Innocenti B., Giardinelli L. Epidemiology of anxiety disorders in Florence. Acta Psychiatr Scand. 79:1989;308-312.
17. Faravelli C., Zucchi T., Viviani B., Salmoria R., Perone A. Epidemiology of social phobia: a clinical approach. Eur Psychiatry. 15:2000;17-24.
18. Godart N.T., Flament M.F., Lecrubier Y., Jeammet P. Anxiety disorders in anexoria nervosa: Co-morbidity and chronology of appearance. Eur Psychiatry. 15:2000;38-45.
19. Heimberg R.G., Stein M.B., Hirirpi E.V.A., Kessler R.C. Trends in the prevalence of social phobia in the United States: A synthetic cohort analysis of changes over four decades. Eur Psychiatry. 15:2000;29-37.
20. Kessler R.C., McGonagle K.A., Zhao S., et al. Lifetime and 12-month prevalence of DSM-IIIR psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 51:1994;8-19.
21. Kessler R.C., Crum R.M., Warner L.A., Nelson C.B., Schulenberg J., Anthony J.C. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Study. Arch Gen Psychiatry. 54:1997;313-321.
22. Kessler R.C., Stang P., Wittchen H.U., Stein M., Walters E.E. Lifetime comorbidities between social phobia and mood disorders in the US National Comorbidity Survey. Psychol M. 29:1999;555-567.
23. Lecrubier Y., Weiller E. Comorbidities in social phobia. Int Clin Pyschopharmacol. 12:1997;S17-21.
24. Lépine J.P., Lellouch J. Diagnosis and epidemiology of agoraphobia and social phobia. Clin Neuropharmacol. 18:1995;S15-26.
25. Lépine J.P., Pélissolo A. Epidemiology and comorbidity of social anxiety disorder. Westenberg H.G.M, den Boer J.A. Focus on Psychiatry. Social anxiety disorder. 1999;29-43 Amsterdam: Syn-Thesis Publishers.
26. Lindal E., Stefansson J.G. The lifetime prevalence of anxiety disorders in Iceland as estimated by the US National Institute of Mental Health Diagnostic Interview Schedule. Acta Psychiatr Scand. 88:1993;29-34.
27. Magee W.J., Eaton W.W., Wittchen H.U., McGonagle K.A., Kessler R.C. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry. 53:1996;159-168.
28. Merikangas K.R., Angst J. Comorbidity and social phobia; evidence from clinical, epidemiologic, and genetic studies. Eur Arch Psychiatry Clin Neurosci. 244:1995;297-303.
29. Pakriev S., Vasar V., Aluoja A., Saarma M., Shlik J. Prevalence of mood disorders in the rural population of Udmurtia. Acta Psychiatr Scand. 97:1998;169-174.
30. Pini S., Cassano G.B., Simonini E., Savino M., Russo A., Montgomery S.A. Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. J Affect Disord. 42:1997;145-153.
31. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA. 264:1990;2511-2518.
32. Schneier F.R., Johnson J., Hornig C.D., Liebowitz M.R., Weissman M.M. Social phobia. Comorbidity and morbidity in an epidemiological sample. Arch Gen Psychiatry. 49:1992;282-288.
33. Stein M.B., Chavira D.A. Subtypes of social phobia and comorbidity with depression and other anxiety disorders. J Affect Disord. 50 (Suppl. 1):1998;S11-16.
34. Szadoczky E., Rihmer Z., Papp Z.S., Furedi J. The prevalence of affective and anxiety disorders in primary care practice in Hungary. J Affect Disord. 43:1997;239-244.
35. Turner S.M., Beidel D.C., Larkin K.T. Situational determinants of social anxiety in clinic and nonclinic samples; physiological and cognitive correlates. J Consult Clin Psychol. 54:1986;523-527.
36. Wacker H.R., Mulleians R., Klein K.H., Battegay R. Identification of cases of anxiety disorders and affective disorders in the community according to ICD-10 and DSM-IIIR by using the composite international diagnostic interview (CIDI). Int J Meth Psychiat Research. 2:1992;91-100.
37. Weiller E., Bisserbe J.C., Boyer P., Lépine J.P., Lecrubier Y. Social phobia in general health care. An unrecognised undertreated disabling disorder. Br J Psychiatry. 168:1996;169-174.
38. Wittchen H.U., Beloch E. The impact of social phobia on quality of life. Int Clin Psychopharmacol. 11:1996;15-23.
39. Wittchen H.U., Ahmoi Essau C., von Zerssen D., Krieg J.-C., Zaudig M. Lifetime and six-month prevalence of mental disorders in the Munich follow-up study. Eur Arch Psychiatry Neurosci. 241:1992;247-258.
40. Wittchen H.U., Nelson C.B., Lachner G. Prevalence of mental disorders and psychosocial impairments in adolescents and young adults. Psychol M. 28:1998;109-126.
41. Wittchen H.U., Stein B., Kessler R. Social fears and social phobia in a community sample of adolescents and young adults: prevalence, risk factors, and comorbidity. Psychol M. 29:1999;309-323.
42. Wittchen H.U., Feutsch M., Sonntag H., Muller N., Liebowitz M. Disability and quality of life in pure and comorbid social phobia: findings from a controlled study. Eur Psychiatry. 15:2000;46-58.
43. Wunderlich U., Bronisch T., Wittchen H.U. Comorbidity patterns in adolescents and young adults with suicide attempts. Eur Arch Psychiatry Clin Neurosci. 248:1998;87-95.